Accredited Educational Activities

IMMERSIVE SIMULATION EXPERIENCE

Vision RELIEF: Navigating Anti-VEGF Treatment Options to Optimize Treatment Individualization

This Immersive Simulation Experience in diabetic retinopathy (DR), neovascular age-related macular degeneration (nAMD) and retinal vein occlusion (RVO) allows learners to engage in clinical decision-making to individualize treatment with anti-vascular endothelial growth factor (anti-VEGF) therapies. By participating in this simulated 3D encounter, you will observe patient-provider interactions and use pertinent information from the patients’ electronic chart to decide the next best course of action at various key points in care, including identifying eyes that may benefit from anti-VEGF treatment, incorporating assessment of efficacy and safety data into treatment decisions, and strategizing changes in treatment approach to achieve optimal outcomes.

New Insights on the Diagnosis and Treatment of Retinal Vein Occlusion

This enduring program targets critical issues in retinal vein occlusion (RVO), including risk for RVO, how early treatment can help prevent progression to vision-threatening complications, and treatment strategies for complications of RVO, particularly RVO-related macular edema. Learn essential elements of assessment and management, as well as clinical trial data on the latest approaches in care, helping to preserve vision in retinal vein occlusion.

A Close Look at the Diagnosis and Treatment of Patients with Retinal Vascular Disease

This online activity targets healthcare gaps related to the diagnosis and management of diabetic retinopathy (DR), age-related macular degeneration (AMD), and retinal vein occlusion (RVO), impacting outcomes through risk stratification, diagnostic strategies, and treatment individualization with anti-VEGF agents.